Premium
Sci‐Fri PM: Planning‐04: Dose escalation study using anatomy‐based aperture IMRT and SPECT perfusion images for lung cancer
Author(s) -
StHilaire J,
Lavoie C,
Beaulieu F,
Dagnault A,
Morin F,
Gingras L,
Tremblay D,
Beaulieu L
Publication year - 2008
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.2965976
Subject(s) - nuclear medicine , lung cancer , medicine , medical physics , cancer , radiation treatment planning , radiology , radiation therapy , oncology
In the case of non‐small cell lung cancer, doses typically prescribed (60–66 Gy) are not sufficient to ensure a satisfactory tumor control probability. Dose escalation needs to be realized, but dose to organs at risk (OARs) must be kept under widely accepted clinical thresholds. Also, lung functionality is not homogeneously distributed over all the volume: single‐photon emission computed tomography (SPECT) allows spatial characterization of perfusion, open the way to the design of treatments plans that could preferentially avoid highly‐functional lung. In this study, three cases of lung cancer were retrospectively used to assess the capacity of an anatomy‐based aperture inverse planning system to realize dose escalation while limiting dose to perfused lung. Plans were generated for four‐beam non‐coplanar configurations, mixing 6 and 23 MV photon beams. All dose calculations were performed using Pinnacle 3 superposition/convolution algorithm. An increasing dose was prescribed to a subvolume of the initial planning target volume. Levels of escalation achieved for the three cases studied were 81 Gy, 111 Gy and 66 Gy to the subvolume. Escalation was limited in two cases by the dose to the esophagus and in the other case by the presence of overdosages near beam entry ports. Calculation of dose‐volume parameters for OARs shows that they respect clinical thresholds. Plans generated by the system are less complex than plans generated in beamlet‐based IMRT, because of the use of few, large segments. The approach used in this study allows important dose escalation, potentially improving treatment outcome.